Board of Directors

Goodwin Biotechnology is honored to work with a distinguished group of individuals who make up our Board of Directors, each of whom have independently exemplified extensive experience growing companies who are in the field of biologics. Each member of the board is committed to providing an independent, objective source of advice and counsel, and in helping guide Goodwin in its mission as the company continues to develop and manufacture highly complex, targeted biopharmaceuticals in a cost effective and timely manner.

We have put together a team of true industry professionals to guide Goodwin as it scales into the future as an appropriately sized and equipped organization aimed at efficiently managing the complexity of biopharmaceuticals and providing our clients with the ability to simplify their manufacturing supply chains with our Single Source Solution™ approach to our world class services.”

Karl Pinto, Chief Executive Officer and Chairman of the Board.
Karl Pinto Headshot
Read Bio
Karl Pinto, MBA
Chief Executive Officer & Chairman of the Board
Divya Menezes, MD
Read Bio
Divya Menezes, MD
Board Member
Brandon J. Price, Ph.D.
Read Bio
Brandon J. Price, Ph.D.
Board Member
Kent Payne
Read Bio
Kent Payne, Ph.D.
Board Member
Nikhil Puri
Read Bio
Nikhil Puri
Board Member
genome watermark
005 International Messaging

Reach Out

To a specialist